To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cas No.: | 174671-46-6 |
| Synonyms: | Tavaborole; AN2690; AN 2690 |
| SMILES: | OB1OCC2=CC(F)=CC=C21 |
| Formula: | C7H6BFO2 |
| M.Wt: | 151.93 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | AN-2690, a broad-spectrum drug, is a very promising candidate for treatment of ungual and periungual infections with improved nail penetration and low keratin binding. AN-2690 is an antifungal agent with activity against Trichophyton species. AN-2690 inhibits yeast cytoplasmic leucyl-tRNA synthetase by Formation of a stable tRNA(Leu)-AN2690 adduct in the editing site of the enzyme. AN-2690 is currently in clinical trials For onychomycosis topical treatment.For the detailed information of AN-2690(Tavaborole), the solubility of AN-2690(Tavaborole) in water, the solubility of AN-2690(Tavaborole) in DMSO, the solubility of AN-2690(Tavaborole) in PBS buffer, the animal experiment (test) of AN-2690(Tavaborole), the cell expriment (test) of AN-2690(Tavaborole), the in vivo, in vitro and clinical trial test of AN-2690(Tavaborole), the EC50, IC50,and Affinity of AN-2690(Tavaborole), Please contact DC Chemicals. |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|